The effectiveness of meropenem and amikacin combination therapy against Carbapenemase-producing Klebsiella pneumoniae pneumonia mouse model
Main Authors: | K. Ota, N. Kaku, N. Uno, K. Sakamoto, Y. Morinaga, H. Hasegawa, T. Miyazaki, K. Izumikawa, H. Mukae, K. Yanagihara |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | International Journal of Infectious Diseases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971220307700 |
Similar Items
-
Comparison of the Efficacy of Colistin and Meropenem Monotherapy with Meropenem/Ertapenem Combination in an Experimental Sepsis Model of Carbapenemase-producing Klebsiella pneumoniae
by: Deniz YÜCE YILDIRIM, et al.
Published: (2022-12-01) -
Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacin
by: Hung-Jen Tang, et al.
Published: (2019-04-01) -
In vitro-obtained meropenem-vaborbactam resistance mechanisms among clinical Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates
by: Jacqueline Findlay, et al.
Published: (2023-03-01) -
Synergetic Effects of Combined Treatment of Colistin With Meropenem or Amikacin on Carbapenem-Resistant Klebsiella pneumoniae in vitro
by: Lan Yu, et al.
Published: (2019-12-01) -
Review of In Vitro Efficacy of Ceftazidime-Avibactam, Meropenem-Vaborbactam and Imipenem-Relebactam in Carbapenemase Producing Klebsiella pneumoniae Isolates
by: Özlem AYDEMİR, et al.
Published: (2023-09-01)